Apelin-13 сoncentration in patients with essential hypertension, extrasystole and obesity.
| dc.contributor.author | Kuzminova, Nataliia | |
| dc.contributor.author | Ivankova, Anastasiya | |
| dc.contributor.author | Romanova, Valentyna | |
| dc.contributor.author | Kalitai, Volodymyr | |
| dc.contributor.author | Kulchytska, Olena | |
| dc.contributor.author | Knyazkova, Iryna | |
| dc.date.accessioned | 2023-12-01T11:47:54Z | |
| dc.date.available | 2023-12-01T11:47:54Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Today metabolic markers of cardiovascular risk are being actively studied. One of them is apelin-13. Objective: To assess the concentration of apelin-13 in patients with hypertension and extrasystole depending on obesity. | en_US |
| dc.identifier.citation | Apelin-13 сoncentration in patients with essential hypertension, extrasystole and obesity / N. V. Kuzminova, A. V. Ivankova, V. O. Romanova, V. V. Kalitai, O. M. Kulchytska, I. I. Knyazkova // Journal of Obesity and Chronic Diseases. – 2023. – Volume 7, Supplement 1: Proceeding of 7th International Obesity and Metabolic Disorders Research Conference (ORC – 2023). – Р. S13–S14. | en_US |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/33280 | |
| dc.language.iso | en | en_US |
| dc.subject | apelin-13 | en_US |
| dc.subject | essential hypertension | en_US |
| dc.subject | extrasystole | en_US |
| dc.subject | obesity | en_US |
| dc.subject | 2023а | en_US |
| dc.title | Apelin-13 сoncentration in patients with essential hypertension, extrasystole and obesity. | en_US |
| dc.type | Thesis | en_US |